Results 21 to 30 of about 30,877 (270)

Acute Intoxication by Bisoprolol and Drowning: Toxicological Analysis in Complex Suicides

Separations, 2023
In complex suicides, more than one suicide method is applied at the same time or one after the other. The most common complex suicide includes the ingestion of drugs combined with drowning.
A. Carfora, Raffaella Petrella, Giusy Ambrosio, Ilaria Fracassi, S. Festinese, Bruno Liguori, C. Campobasso   +6 more
semanticscholar   +1 more source

β1-adrenergic receptor polymorphisms: a possible genetic predictor of bisoprolol response in acute coronary syndrome

Future Science OA, 2023
Aim: To investigate the association between beta1-adrenergic receptor (ADRB1) polymorphisms and response to bisoprolol treatment in beta-blocker naive patients with acute coronary syndrome (ACS).
Mohamed S Fayed, M. Saleh, N. Sabri, Amal A Elkholy   +3 more
semanticscholar   +1 more source

A Comparative Study to Investigate the Effects of Bisoprolol in Patients with Chronic Heart Failure and Hypertension When Switched from Tablets to Transdermal Patches

Journal of Personalized Medicine, 2023
Background: Oral beta-blockers are effective for heart failure and hypertension. Here, we conducted a prospective study to investigate the efficacy of the beta-blocker bisoprolol in patients switching from the oral tablet to the transdermal patch ...
A. Sezai, H. Sekino, M. Taoka, S. Osaka, Masashi Tanaka   +4 more
semanticscholar   +1 more source

CONSENSUS TOWARDS THE UTILISATION OF BISOPROLOL IN COMBINATION WITH TELMISARTAN IN INDIAN PATIENTS WITH HYPERTENSION

Stable IHD/Prevention/Hypertension/Lipids, 2023
Objective: To formulate a consensus statement for the utilization of bisoprolol in combination with telmisartan based on the contemporary evidence and the real-world experiences of the Indian cardiologists Design and method: A virtual collaborative ...
J. Sawhney, Rajeev Garg, J. Makkar, S. Dani, S. Guha, J. Dalal, S. Ray, R. Agarwal, Upendra Kaul, D. Solanki   +9 more
semanticscholar   +1 more source

Effect of Digoxin vs Bisoprolol for Heart Rate Control in Atrial Fibrillation on Patient-Reported Quality of Life: The RATE-AF Randomized Clinical Trial.

Journal of the American Medical Association (JAMA), 2020
Importance There is little evidence to support selection of heart rate control therapy in patients with permanent atrial fibrillation, in particular those with coexisting heart failure. Objective To compare low-dose digoxin with bisoprolol (a β-blocker)
D. Kotecha, K. Bunting, S. Gill, S. Mehta, Mary Stanbury, Jacqueline Jones, Sandra Haynes, M. Calvert, J. Deeks, R. Steeds, V. Strauss, K. Rahimi, A. Camm, Michael Griffith, G. Lip, J. Townend, P. Kirchhof   +16 more
semanticscholar   +1 more source

P10 Initiation of bisoprolol in paediatric patients – experience from a specialist paediatric cardiac centre

Archives of Disease in Childhood, 2023
Aim Given the lack of published dosing information to guide the use of bisoprolol in our paediatric cardiology patients, we assessed the safety and tolerability of initiation and maintenance doses of bisoprolol in a cohort of children with congenital ...
A. Bueno Gómez, Mary Healy, Grazia Delle Donne, S. Bentley, Sukeshi Makhecha, P. Daubeney, N. Naqvi, J. Till, Leonie Wong   +8 more
semanticscholar   +1 more source

Clinical and molecular characterization of a cardiac ryanodine receptor founder mutation causing catecholaminergic polymorphic ventricular tachycardia [PDF]

, 2015
Background Catecholaminergic polymorphic ventricular tachycardia (CPVT) is a difficult-to-diagnose cause of sudden cardiac death (SCD). We identified a family of 1400 individuals with multiple cases of CPVT, including 36 SCDs during youth.
Allegue, Catarina, Beltran-Alvarez, Pedro, Berne, Paola, Bosch Calero, Cristina, Brugada, Josep, Brugada, Ramon, Campuzano, Oscar, Iglesias, Anna, Pérez, Carmelo, Pérez, Guillermo J., Ruiz Hernandez, Pablo M., Scornik, Fabiana S., Wangüemert, Fernando   +12 more
core   +2 more sources

Bisoprolol Delays Progression Towards Right Heart Failure in Experimental Pulmonary Hypertension [PDF]

, 2012
Background— In pulmonary arterial hypertension (PH), sympathetic adrenergic activity is highly elevated. Sympathetic overactivity is a compensatory mechanism at first, but might be detrimental for cardiac function in the long run.
Ballegoij, J.J.M. van, Bogaards, S.J.P., Handoko, M.L., Man, F.S. de, Paulus, W.J., Postmus, P.E., Schalij, I., Velden, J. van der, Vonk Noordegraaf, A., Westerhof, N.   +9 more
core   +2 more sources

Impact of Renal Impairment on Beta-Blocker Efficacy in Patients With Heart Failure. [PDF]

, 2019
BACKGROUND: Moderate and moderately severe renal impairment are common in patients with heart failure and reduced ejection fraction, but whether beta-blockers are effective is unclear, leading to underuse of life-saving therapy.
Andersson, B, Anker, SD, Beta-Blockers in Heart Failure Collaborative Group, Böhm, M, Cleland, JGF, Coats, AJS, Damman, K, Flather, MD, Gill, SK, Holmes, J, Kjekshus, J, Kotecha, D, Manzano, L, McMurray, JJV, Packer, M, Redon, J, Rigby, AS, Rosano, G, Ruschitzka, F, van Veldhuisen, DJ, von Lueder, TG, Wedel, H, Wikstrand, J   +22 more
core   +8 more sources

Cardiopulmonary interactions with beta-blockers and inhaled therapy in COPD [PDF]

, 2017
Background: Beta-blockers remain underused in patients with COPD and cardiovascular disease. Aim: We compared how different inhaled therapies affect tolerability of bisoprolol and carvedilol in moderate to severe COPD.
Anderson, W., Jabbal, S., Lipworth, B. J., Manoharan, A., Morrison, A., Short, P.   +5 more
core   +2 more sources